Valid for Submission
E85.81 is a billable diagnosis code used to specify a medical diagnosis of light chain (al) amyloidosis. The code E85.81 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code E85.81 might also be used to specify conditions or terms like al amyloidosis, amyloid light-chain nephropathy, amyloid nephropathy or light chain disease.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code E85.81 are found in the index:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- AL amyloidosis
- Amyloid light-chain nephropathy
- Amyloid nephropathy
- Light chain disease
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|545||CONNECTIVE TISSUE DISORDERS WITH MCC||08||2.4995|
|546||CONNECTIVE TISSUE DISORDERS WITH CC||08||1.2066|
|547||CONNECTIVE TISSUE DISORDERS WITHOUT CC/MCC||08||0.833|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
E8581 replaces the following previously assigned ICD-10 code(s):
Convert E85.81 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code E85.81 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.